Feb 28, 2024

Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

Posted by in category: biotech/medical

Research targeting the insulin-inhibitory receptor, or inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy.

A novel study in mice with diet-induced obesity demonstrates that the knock-out of inceptor enhances , prompting its further exploration as a for type 2 treatment.

These findings, led by Helmholtz Munich in collaboration with the German Center for Diabetes Research, the Technical University of Munich, and the Ludwig-Maximilians-University Munich, drive advancements in diabetes research. They have been published in Nature Metabolism.

Leave a reply